2025
SJR Q1
JCR Q2 · 5,1
4 matched articles
SCIE
Journal detail
Tissue Engineering and Regenerative Medicine
- Publisher
- Korean Tissue Engineering and Regenerative Medicine Society
- Country
- South Korea · Asiatic Region
- Type
- journal
- ISSN
-
1738269622125469
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,97
- Quartile Q1
- H-Index 50
- Cites/doc 5,33
- Docs (3y) 274
- Cites (3y) 1.353
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 5,1
- 5Y JIF 4,9
- JCI 0,79
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Biomedical Engineering Q1
- Medicine (miscellaneous) Q1
Areas
- Engineering
- Medicine
WoS categories
- Cell & Tissue Engineering | Engineering, Biomedical
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 0,97 | 5,1 | 4,9 | 0,79 | Q2 | 50 |
| 2024 | Q1 | Q2 | 0,978 | 4,1 | 4,2 | 0,79 | Q2 | 43 |
| 2023 | Q2 | Q2 | 0,77 | 4,4 | 3,9 | 0,77 | Q2 | 43 |
| 2022 | Q2 | Q3 | 0,669 | 3,6 | 3,6 | 0,71 | Q2 | 43 |
| 2021 | Q2 | Q2 | 0,732 | 4,5 | 3,7 | 0,74 | Q2 | 43 |
| 2020 | Q2 | Q2 | 0,719 | 4,2 | 2,8 | 0,63 | Q3 | 43 |
| 2019 | Q2 | Q3 | 0,551 | 2,4 | 1,6 | 0,5 | Q3 | 43 |
| 2018 | — | Q2 | — | 2,3 | 1,5 | 0,39 | Q3 | — |
| 2017 | Q3 | Q4 | 0,327 | 1,2 | 1 | 0,3 | Q4 | 43 |
| 2016 | Q3 | Q3 | 0,359 | 1,2 | 0,9 | — | — | 43 |
| 2015 | Q3 | Q4 | 0,321 | 0,9 | 0,7 | — | — | 43 |
| 2014 | Q3 | Q4 | 0,313 | 1,1 | 0,5 | — | — | 43 |
| 2013 | Q3 | Q4 | 0,247 | 0,6 | 0,3 | — | — | 43 |
| 2012 | Q3 | Q4 | 0,19 | 0,3 | 0,2 | — | — | 43 |
| 2011 | Q3 | — | 0,202 | — | — | — | — | 43 |
| 2010 | Q3 | — | 0,141 | — | — | — | — | 43 |
| 2009 | — | Q1 | — | 3,2 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 10/32 |
| 2025 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q2 | 37/130 |
| 2024 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 13/32 |
| 2024 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q2 | 45/124 |
| 2023 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q3 | 11/31 |
| 2023 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q2 | 36/123 |
| 2022 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q3 | 18/29 |
| 2022 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q2 | 49/96 |
| 2021 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q3 | 14/29 |
| 2021 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q2 | 40/98 |
| 2020 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q3 | 15/29 |
| 2020 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q3 | 28/89 |
| 2019 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q3 | 24/29 |
| 2019 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 45/87 |
| 2018 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 22/26 |
| 2018 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q3 | 40/80 |
| 2017 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 22/24 |
| 2017 | ENGINEERING, BIOMEDICAL | SCIE | Q4 | Q4 | 60/78 |
| 2016 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 21/21 |
| 2016 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | — | 54/77 |
| 2015 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 21/21 |
| 2015 | ENGINEERING, BIOMEDICAL | SCIE | Q4 | — | 62/76 |
| 2014 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 21/21 |
| 2014 | ENGINEERING, BIOMEDICAL | SCIE | Q4 | — | 58/76 |
| 2013 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 18/18 |
| 2013 | ENGINEERING, BIOMEDICAL | SCIE | Q4 | — | 69/76 |
| 2012 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 16/17 |
| 2012 | ENGINEERING, BIOMEDICAL | SCIE | Q4 | — | 72/79 |
| 2009 | CELL & TISSUE ENGINEERING | SCIE | Q3 | — | 7/12 |
| 2009 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | — | 10/59 |